Back to search
FDAFDA · Food and drugs·Recall number D-0519-2023

Rosuvastatin Tablets, USP, 10 mg, Packaged as: a) 30-count bottle (NDC 68788-7086-3); b) 90-count bottle (NDC 68788-7086-9), Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703.

Published April 12, 2023 · Recall initiated: March 23, 2023

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

What to do

Voluntary: Firm initiated · Letter

Recall details

Brand
ROSUVASTATIN CALCIUM
Manufacturer
Preferred Pharmaceuticals, Inc.
Distributor
USA Nationwide
Lot
a) Lot: F2022N, Exp. Date: 2/29/2024; b) Lot: F0322I, Exp. Date: 8/31/2023; Lot: J1322H, Exp. Date: 2/29/2024; Lot: K0222N, Exp. Date: 6/30/2024; Lot: L2322D and Lot: L2822J, Exp. Date:7/31/2025.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Sell products like this?

Recalert watches your whole catalog for recalls like this one, automatically.

Start free — no card